Navigation Links
Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
Date:8/19/2007

-T, risks and uncertainties surrounding the presentation of data to the FDA and approval of product applications by the FDA and risks and uncertainties inherent in the process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeutics. Factors that may cause such differences include risks associated with completing our clinical trials, the risk that the safety and/or efficacy results of existing clinical trials or from additional clinical trials for PROVENGE or NEUVENGE will not support approval for a biologics license, the risk that the FDA may interpret data differently than we do or require more data or a more rigorous analysis of data than expected, the risk that the results of a clinical trial for PROVENGE, NEUVENGE or other product may not be indicative of results obtained in a later clinical trial, risks that we may lack the financial resources and access to capital to fund required clinical trials or commercialization of PROVENGE, our dependence on the efforts of third parties, and our dependence on intellectual property. Further information on the factors and risks that could affect Dendreon's business, financial condition and results of operations are contained in Dendreon's public disclosure filings with the U.S. Securities and Exchange Commission, which are available at http://www.sec.gov.


'/>"/>
SOURCE Dendreon Corporation

Copyright©2007 PR Newswire.

Page: 1 2 3 4

Related medicine technology :

1. Dendreon Announces Presentation of Data at American Urological Association Annual Meeting
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Sygnis Pharma AG announces date for presentation of clinical results
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
7. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
8. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Protox Announces Positive Clinical Data from Prostate Cancer Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... NORTH CHICAGO, Ill. , Sept. 22, 2014 ... that data from several clinical studies evaluating potential ... be presented at the upcoming 2014 European Society ... in Madrid, Spain . Data ... study evaluating the safety and efficacy of veliparib ...
(Date:9/22/2014)... 22, 2014  CorMedix Inc. (NYSE MKT: CRMD), ... therapeutic products for the prevention and treatment of ... announce that TUV-SUD and The Medicinal Evaluation Board ... has granted its request for a label expansion ... initially approved in July 2013 for use in ...
(Date:9/22/2014)... YORK , Sept. 22, 2014 ... exclusive, global license agreement with Plasma Technologies LLC ... proprietary plasma fractionation process. Concurrently, the Company announced ... to strategically refocus and rebrand the company as ... a national listing for its common shares. ...
Breaking Medicine Technology:AbbVie to Present Clinical Study Data on Potential New Oncology Medicines at the 2014 European Society of Medical Oncology Annual Meeting 2AbbVie to Present Clinical Study Data on Potential New Oncology Medicines at the 2014 European Society of Medical Oncology Annual Meeting 3AbbVie to Present Clinical Study Data on Potential New Oncology Medicines at the 2014 European Society of Medical Oncology Annual Meeting 4Neutrolin Label Expansion Approved for the European Union 2Neutrolin Label Expansion Approved for the European Union 3Access Pharmaceuticals Announces Exclusive Global Plasma Therapeutics License, New Management And New Corporate Name 2Access Pharmaceuticals Announces Exclusive Global Plasma Therapeutics License, New Management And New Corporate Name 3Access Pharmaceuticals Announces Exclusive Global Plasma Therapeutics License, New Management And New Corporate Name 4Access Pharmaceuticals Announces Exclusive Global Plasma Therapeutics License, New Management And New Corporate Name 5Access Pharmaceuticals Announces Exclusive Global Plasma Therapeutics License, New Management And New Corporate Name 6
... The Perrigo Company (Nasdaq: PRGO;TASE) today announced that ... Drug Administration (FDA) to market over-the-counter coated nicotine polacrilex ... The product will be marketed under store ... Surge™ coated gum, which is a stop smoking aid. ...
... 2011 Reportlinker.com announces that a ... in its catalogue: ... US and its International Trade [2011 ... http://www.reportlinker.com/p0574385/Pharmaceutical-Preparation-Manufacturing-Industry-in-the-US-and-its-International-Trade- [2011-Q3-Edition].html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_ This latest ...
Cached Medicine Technology:Perrigo Receives FDA Approval to Market Coated Cinnamon Nicotine Gum 2Pharmaceutical Preparation Manufacturing Industry in the US and its International Trade [2011 Q3 Edition] 2Pharmaceutical Preparation Manufacturing Industry in the US and its International Trade [2011 Q3 Edition] 3Pharmaceutical Preparation Manufacturing Industry in the US and its International Trade [2011 Q3 Edition] 4Pharmaceutical Preparation Manufacturing Industry in the US and its International Trade [2011 Q3 Edition] 5
(Date:9/22/2014)... - Neurosurgeons have treated head and spinal sports injuries ... century, with formal efforts to mitigate these injuries dating ... is a comprehensive, 16-article supplement of ... of Neurological Surgeons , published by Lippincott Williams & ... a detailed, fascinating history of concussion treatment and research. ...
(Date:9/22/2014)... September 22, 2014 Research reveals that ... hGH , significantly declines during the aging process. This ... and tear, such as wrinkles, droopy skin, weakened muscles ... Elevation of Pulsatile Growth Hormone (GH) Secretion and Insulin-Like ... individuals thus, triggering the aging process. , Decades ...
(Date:9/22/2014)... Video: Preventing Diabetes After ... University Medical Center now offers autologous islet cell ... in patients who require a total pancreatectomy. The ... York metropolitan area to offer this treatment. ... United States receive surgical treatment for pancreatitis, a ...
(Date:9/22/2014)... QueenBeeTickets.com has the largest inventory on the ... Stevie Wonder tickets. The phenomenal singer/songwriter has announced his ... cities have been put on the schedule to receive ... Here to view the selection of discounted seats ... ticket sales are bound to be high for upcoming ...
(Date:9/22/2014)... Viejo, California (PRWEB) September 22, 2014 ... release of ProSparkle. A fully customizable 3D particle emitter ... , “Adding the ProSparkle particle emitter plugin to a ... Said Christina Austin, CEO of Pixel Film Studios. “ProSparkle ... simply described as cool” , With ProSparkle users are ...
Breaking Medicine News(10 mins):Health News:Comprehensive Neurosurgery supplement covers sports-related concussions 2Health News:Comprehensive Neurosurgery supplement covers sports-related concussions 3Health News:Comprehensive Neurosurgery supplement covers sports-related concussions 4Health News:Diet Doc Reveals the Secret to Looking and Feeling Younger with new Prescription Sermorelin hGH Anti-Aging Therapy 2Health News:Diet Doc Reveals the Secret to Looking and Feeling Younger with new Prescription Sermorelin hGH Anti-Aging Therapy 3Health News:New Treatment May Prevent Diabetes After Pancreatitis Surgery 2Health News:New Treatment May Prevent Diabetes After Pancreatitis Surgery 3Health News:Discount Stevie Wonder Tickets: QueenBeeTickets.com Delights Customers with Discounted Concert Tickets for Stevie Wonder’s 11-City Tour Set to Kick off in November 2Health News:Announcing a new ProSparkle Particle Emitter Pack from Pixel Film Studios for Final Cut Pro X Professionals 2
... is Open to the Public, Providing Access to ... Childhood,Illnesses, WASHINGTON, March 19 Mental health,professionals ... will have,an opportunity on Sunday, March 30th, to ... the military and about other serious mental illnesses,including ...
... "Control yourself!" , Most of us haven,t heard that ... we often tell ourselves, consciously or not, as we ... to regulate one,s emotions is critical to successfully interacting ... has an equally important effect on our own well-being. ...
... Imported foods now make up an estimated 10 to ... food imported into the United States in 2007 was $70.5 ... translates into over nine million entries into the United States ... of more than 300 entry points which include ports, border ...
... Ill., March 19 Pregis Corporation, a leading,international ... specialty packaging solutions, today announced its 2007 fourth,quarter ... fourth quarter of 2007, the Company generated net ... net sales of $235.3 million in,the fourth quarter ...
... World Water Day,(March 22), Water Advocates calls for ... projects in developing countries. While,recognizing the important work ... there remains an acute need to ratchet-up actions ... the civic and faith-based,community., "Each day 4,500 ...
... Cholesterol-associated variants increase risk and may be early ... News) -- A combination of cholesterol-associated gene variants ... stroke or sudden cardiac death, Massachusetts General Hospital ... to test for these gene variants in order ...
Cached Medicine News:Health News:NARSAD's 5th Annual 'Mission Possible' Symposium Offers Insight to PTSD and Other Mental Illnesses 2Health News:NARSAD's 5th Annual 'Mission Possible' Symposium Offers Insight to PTSD and Other Mental Illnesses 3Health News:NARSAD's 5th Annual 'Mission Possible' Symposium Offers Insight to PTSD and Other Mental Illnesses 4Health News:Disgusting videos used to study coping methods 2Health News:Disgusting videos used to study coping methods 3Health News:Disgusting videos used to study coping methods 4Health News:Pregis Announces Fouth Quarter and Full Year 2007 Financial Results 2Health News:Pregis Announces Fouth Quarter and Full Year 2007 Financial Results 3Health News:Pregis Announces Fouth Quarter and Full Year 2007 Financial Results 4Health News:Pregis Announces Fouth Quarter and Full Year 2007 Financial Results 5Health News:Pregis Announces Fouth Quarter and Full Year 2007 Financial Results 6Health News:Pregis Announces Fouth Quarter and Full Year 2007 Financial Results 7Health News:Pregis Announces Fouth Quarter and Full Year 2007 Financial Results 8Health News:Pregis Announces Fouth Quarter and Full Year 2007 Financial Results 9Health News:Pregis Announces Fouth Quarter and Full Year 2007 Financial Results 10Health News:Pregis Announces Fouth Quarter and Full Year 2007 Financial Results 11Health News:Water Advocates Calls for More Drinking Water and Sanitation Projects 2Health News:Water Advocates Calls for More Drinking Water and Sanitation Projects 3Health News:Water Advocates Calls for More Drinking Water and Sanitation Projects 4Health News:Water Advocates Calls for More Drinking Water and Sanitation Projects 5Health News:Water Advocates Calls for More Drinking Water and Sanitation Projects 6Health News:Water Advocates Calls for More Drinking Water and Sanitation Projects 7Health News:Gene Variants Can Predict Threat of Heart Disease 2
... PDSHEART provides all equipment, supplies, and all patient ... hookup for setting the patient up in your ... patient), and the professional component, for interpreting the ... service provider to offer full access to your ...
... Cardiac Services is a leading provider ... people, combined with state-of-the-art technology deliver ... that supports healthcare professionals and clients ... uses telecommunications and ECG technology to ...
... microplate incubator is an extremely compact ... single microplate up to 50C. ... requiring higher temperatures up to 65C. ... low cost and high performance for ...
... Incubator/Shaker HT is designed for ... Incubator/Shaker HT is ideal for ... and primer extension assays. iEMS ... a one-cabinet model, allowing the ...
Medicine Products: